CRISPR-produced CAR T cells could better treat solid tumors

Chimeric antigen receptor (CAR) T cells are biological assassins: white blood cells that are specifically engineered to attack cancer cells. Over the past five years, they’ve become an established therapeutic option for patients with blood …

Growing a New Type of Organ Donor

Not enough human organs are available for all the people who need life-saving transplants, despite longstanding efforts to solve the problem. So scientists are turning to a new group of potential donors: pigs. They are …

Government price controls could threaten UW research

By Erik Iverson, Chief Executive Officer, Wisconsin Alumni Research Foundation Those of us engaged in Wisconsin’s innovation economy had a good summer. The recently passed CHIPS and Science Act authorizes historic investments in research that …

Discovery to Product adds Grant Program

UW–Madison Innovators Eligible A new Piloting Research Innovation & Market Exploration (PRIME) grant program will support critical research needed for commercialization of innovations developed at UW–Madison. Administered by UW-Madison’s Discovery to Product (D2P), successful project …

Where innovation is needed most in healthcare

Innovative solutions are needed in almost every aspect of healthcare including its delivery to consumers, its technology and its business models. Three health system chief innovation officers told Becker’s areas where healthcare innovation can grow. …